Report Detail

Request for Sample of this report

Other Global Cancer Gene Therapy Professional Survey Report 2020, Forecast to 2025

  • RnM4234864
    • |
  • 28 October, 2020
    • |
  • Global
    • |
  • 108 Pages
    • |
  • Multimarket Insight
    • |
  • Other

The report forecast global Cancer Gene Therapy market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period of 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. Estimates of the regional markets for Cancer Gene Therapy are based on the applications market.

The report demonstrates detail coverage of Cancer Gene Therapy industry and main market trends.
The market research includes historical and forecast data, like demand, application details, price trends, and company shares of the leading Cancer Gene Therapy by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Since the COVID-19 virus outbreak in December 2019, the World Health Organization declared it a public health emergency. The desease has spread to over 100 countries and caused huge losses of lives around the globe. Especially the global manufacturing, tourism and financial markets have been hit hard. The downward pressure on the world economy that once showed signs of recovery in the previous period has increased again. The outbreak of the epidemic has added risk factors to the already weak growth of the world economy. Many international organizations have pointed out that the world economy is in the most severe period since the financial crisis.
The negative global impacts of the coronavirus are already there, significantly affecting the Cancer Gene Therapy market in 2020. This report studies and analyzes the in-depth impact of Coronavirus COVID-19 on the Cancer Gene Therapy industry.
In addition, the report provides insight into main drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Cancer Gene Therapy market are discussed. And this report covers the historical situation, present status and the future prospects of the global Cancer Gene Therapy market for 2015-2025.

Market Segment by Product Type
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy

Market Segment by Product Application
Hospitals
Diagnostics Centers
Research Institutes

Finally, the report provides detailed profile and data information analysis of leading company.
Adaptimmune
Amgen
Shanghai Sunway Biotech
Bluebird bio
Altor BioScience
Celgene
BioCancell
SynerGene Therapeutics
Shenzhen SiBiono GeneTech
Argenx
GlaxoSmithKline
Transgene
Merck
OncoGenex Pharmaceuticals

Report Includes:
- xx data tables (appendix tables)
- Overview of global Cancer Gene Therapy market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Cancer Gene Therapy market
- Profiles of major players in the industry, including Adaptimmune, Amgen, Shanghai Sunway Biotech, Bluebird bio, Altor BioScience.....

Research Objectives
1.To study and analyze the global Cancer Gene Therapy consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
2.To understand the structure of Cancer Gene Therapy market by identifying its various subsegments.
3.Focuses on the key global Cancer Gene Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Cancer Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Cancer Gene Therapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    Global Cancer Gene Therapy Professional Survey Report Report 2020, Forecast to 2025

      1 Market Overview

      • 1.1 Cancer Gene Therapy Definition
        • 1.1.1 Analysis of Macroeconomic Indicators
        • 1.1.2 Years Considered
      • 1.2 Cancer Gene Therapy Segment by Type
        • 1.2.1 Oncolytic Virotherapy
        • 1.2.2 Gene Transfer
        • 1.2.3 Gene-Induced Immunotherapy
      • 1.3 Market Analysis by Application
        • 1.3.1 Hospitals
        • 1.3.2 Diagnostics Centers
        • 1.3.3 Research Institutes
      • 1.4 Global Cancer Gene Therapy Market Comparison by Regions (2020-2025)
        • 1.4.1 Global Cancer Gene Therapy Market Size (2015-2025)
        • 1.4.2 North America Cancer Gene Therapy Status and Prospect (2015-2025)
        • 1.4.3 Europe Cancer Gene Therapy Status and Prospect (2015-2025)
        • 1.4.4 Asia-Pacific Cancer Gene Therapy Status and Prospect (2015-2025)
        • 1.4.5 South America Cancer Gene Therapy Status and Prospect (2015-2025)
        • 1.4.6 Middle East & Africa Cancer Gene Therapy Status and Prospect (2015-2025)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force
        • 1.5.4 Porter's Five Forces Analysis
        • 1.5.5 SWOT Analysis
      • 1.6 Coronavirus Disease 2019 (Covid-19): Cancer Gene Therapy Industry Impact
        • 1.6.1 How the Covid-19 is Affecting the Cancer Gene Therapy Industry
        • 1.6.2 Cancer Gene Therapy Business Impact Assessment - Covid-19
        • 1.6.3 Market Trends and Cancer Gene Therapy Potential Opportunities in the COVID-19 Landscape
        • 1.6.4 Measures / Proposal against Covid-19

      2 Global Cancer Gene Therapy Market Competition by Manufacturer

      • 2.1 Global Cancer Gene Therapy Sales and Market Share by Manufacturer (2018-2020)
      • 2.2 Global Cancer Gene Therapy Revenue and Market Share by Manufacturer (2018-2020)
      • 2.3 Global Cancer Gene Therapy Industry Concentration Ratio (CR5 and HHI)
      • 2.4 Top 5 Cancer Gene Therapy Manufacturer Market Share
      • 2.5 Top 10 Cancer Gene Therapy Manufacturer Market Share
      • 2.6 Date of Key Manufacturers Enter into Cancer Gene Therapy Market
      • 2.7 Key Manufacturers Cancer Gene Therapy Product Offered
      • 2.8 Mergers & Acquisitions Planning

      3 Analysis of Cancer Gene Therapy Industry Key Manufacturers

      • 3.1 Adaptimmune
        • 3.1.1 Company Details
        • 3.1.2 Product Information
        • 3.1.3 Adaptimmune Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.1.4 Main Business Overview
        • 3.1.5 Adaptimmune News
      • 3.2 Amgen
        • 3.2.1 Company Details
        • 3.2.2 Product Information
        • 3.2.3 Amgen Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.2.4 Main Business Overview
        • 3.2.5 Amgen News
      • 3.3 Shanghai Sunway Biotech
        • 3.3.1 Company Details
        • 3.3.2 Product Information
        • 3.3.3 Shanghai Sunway Biotech Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.3.4 Main Business Overview
        • 3.3.5 Shanghai Sunway Biotech News
      • 3.4 Bluebird bio
        • 3.4.1 Company Details
        • 3.4.2 Product Information
        • 3.4.3 Bluebird bio Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.4.4 Main Business Overview
        • 3.4.5 Bluebird bio News
      • 3.5 Altor BioScience
        • 3.5.1 Company Details
        • 3.5.2 Product Information
        • 3.5.3 Altor BioScience Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.5.4 Main Business Overview
        • 3.5.5 Altor BioScience News
      • 3.6 Celgene
        • 3.6.1 Company Details
        • 3.6.2 Product Information
        • 3.6.3 Celgene Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.6.4 Main Business Overview
        • 3.6.5 Celgene News
      • 3.7 BioCancell
        • 3.7.1 Company Details
        • 3.7.2 Product Information
        • 3.7.3 BioCancell Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.7.4 Main Business Overview
        • 3.7.5 BioCancell News
      • 3.8 SynerGene Therapeutics
        • 3.8.1 Company Details
        • 3.8.2 Product Information
        • 3.8.3 SynerGene Therapeutics Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.8.4 Main Business Overview
        • 3.8.5 SynerGene Therapeutics News
      • 3.9 Shenzhen SiBiono GeneTech
        • 3.9.1 Company Details
        • 3.9.2 Product Information
        • 3.9.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.9.4 Main Business Overview
        • 3.9.5 Shenzhen SiBiono GeneTech News
      • 3.10 Argenx
        • 3.10.1 Company Details
        • 3.10.2 Product Information
        • 3.10.3 Argenx Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.10.4 Main Business Overview
        • 3.10.5 Argenx News
      • 3.11 GlaxoSmithKline
        • 3.11.1 Company Details
        • 3.11.2 Product Information
        • 3.11.3 GlaxoSmithKline Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.11.4 Main Business Overview
        • 3.11.5 GlaxoSmithKline News
      • 3.12 Transgene
        • 3.12.1 Company Details
        • 3.12.2 Product Information
        • 3.12.3 Transgene Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.12.4 Main Business Overview
        • 3.12.5 Transgene News
      • 3.13 Merck
        • 3.13.1 Company Details
        • 3.13.2 Product Information
        • 3.13.3 Merck Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.13.4 Main Business Overview
        • 3.13.5 Merck News
      • 3.14 OncoGenex Pharmaceuticals
        • 3.14.1 Company Details
        • 3.14.2 Product Information
        • 3.14.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.14.4 Main Business Overview
        • 3.14.5 OncoGenex Pharmaceuticals News

      4 Global Cancer Gene Therapy Market Size Categorized by Regions

      • 4.1 Global Cancer Gene Therapy Revenue, Sales and Market Share by Regions
        • 4.1.1 Global Cancer Gene Therapy Sales and Market Share by Regions (2015-2020)
        • 4.1.2 Global Cancer Gene Therapy Revenue and Market Share by Regions (2015-2020)
      • 4.2 North America Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 4.3 Europe Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 4.4 Asia-Pacific Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 4.5 South America Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 4.6 Middle East & Africa Cancer Gene Therapy Sales and Growth Rate (2015-2020)

      5 North America Cancer Gene Therapy Market Size Categorized by Countries

      • 5.1 North America Cancer Gene Therapy Sales, Revenue and Market Share by Countries
        • 5.1.1 North America Cancer Gene Therapy Sales by Countries (2015-2020)
        • 5.1.2 North America Cancer Gene Therapy Revenue by Countries (2015-2020)
        • 5.1.3 United States Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 5.1.4 Canada Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 5.1.5 Mexico Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 5.2 North America Cancer Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
      • 5.3 North America Cancer Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
        • 5.3.1 North America Cancer Gene Therapy Sales Market Share by Type (2015-2020)
        • 5.3.2 North America Cancer Gene Therapy Revenue and Revenue Share by Type (2015-2020)
      • 5.4 North America Cancer Gene Therapy Sales Market Share by Application (2015-2020)

      6 Europe Cancer Gene Therapy Market Size Categorized by Countries

      • 6.1 Europe Cancer Gene Therapy Sales, Revenue and Market Share by Countries
        • 6.1.1 Europe Cancer Gene Therapy Sales by Countries (2015-2020)
        • 6.1.2 Europe Cancer Gene Therapy Revenue by Countries (2015-2020)
        • 6.1.3 Germany Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 6.1.4 UK Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 6.1.5 France Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 6.1.6 Russia Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 6.1.7 Italy Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 6.1.8 Spain Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 6.2 Europe Cancer Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
      • 6.3 Europe Cancer Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
        • 6.3.1 Europe Cancer Gene Therapy Sales Market Share by Type (2015-2020)
        • 6.3.2 Europe Cancer Gene Therapy Revenue and Revenue Share by Type (2015-2020)
      • 6.4 Europe Cancer Gene Therapy Sales Market Share by Application (2015-2020)

      7 Asia-Pacific Cancer Gene Therapy Market Size Categorized by Countries

      • 7.1 Asia-Pacific Cancer Gene Therapy Sales, Revenue and Market Share by Countries
        • 7.1.1 Asia-Pacific Cancer Gene Therapy Sales by Countries (2015-2020)
        • 7.1.2 Asia-Pacific Cancer Gene Therapy Revenue by Countries (2015-2020)
        • 7.1.3 China Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 7.1.4 Japan Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 7.1.5 Korea Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 7.1.6 India Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 7.1.7 Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 7.1.8 Australia Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 7.2 Asia-Pacific Cancer Gene Therapy Sales and Revenue (Value) by Manufacturers (2018-2020)
      • 7.3 Asia-Pacific Cancer Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
        • 7.3.1 Asia-Pacific Cancer Gene Therapy Sales Market Share by Type (2015-2020)
        • 7.3.2 Asia-Pacific Cancer Gene Therapy Revenue and Revenue Share by Type (2015-2020)
      • 7.4 Asia-Pacific Cancer Gene Therapy Sales and Market Share by Application (2015-2020)

      8 South America Cancer Gene Therapy Market Size Categorized by Countries

      • 8.1 South America Cancer Gene Therapy Sales, Revenue and Market Share by Countries
        • 8.1.1 South America Cancer Gene Therapy Sales by Countries (2015-2020)
        • 8.1.2 South America Cancer Gene Therapy Revenue by Countries (2015-2020)
        • 8.1.3 Brazil Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 8.2 South America Cancer Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
      • 8.3 South America Cancer Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
        • 8.3.1 South America Cancer Gene Therapy Sales Market Share by Type (2015-2020)
        • 8.3.2 South America Cancer Gene Therapy Revenue and Revenue Share by Type (2015-2020)
      • 8.4 South America Cancer Gene Therapy Sales Market Share by Application (2015-2020)

      9 Middle East and Africa Cancer Gene Therapy Market Size Categorized by Countries

      • 9.1 Middle East and Africa Cancer Gene Therapy Sales, Revenue and Market Share by Countries
        • 9.1.1 Middle East and Africa Cancer Gene Therapy Sales by Countries (2015-2020)
        • 9.1.2 Middle East and Africa Cancer Gene Therapy Revenue by Countries (2015-2020)
        • 9.1.3 GCC Countries Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 9.1.4 Turkey Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 9.1.5 Egypt Cancer Gene Therapy Sales and Growth Rate (2015-2020)
        • 9.1.6 South Africa Cancer Gene Therapy Sales and Growth Rate (2015-2020)
      • 9.2 Middle East and Africa Cancer Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
      • 9.3 Middle East and Africa Cancer Gene Therapy Sales, Revenue and Market Share by Type
        • 9.3.1 Middle East and Africa Cancer Gene Therapy Sales Market Share by Type (2015-2020)
        • 9.3.2 Middle East and Africa Cancer Gene Therapy Revenue and Revenue Share by Type (2015-2020)
      • 9.4 Middle East and Africa Cancer Gene Therapy Sales Market Share by Application (2015-2020)

      10 Global Cancer Gene Therapy Market Segment by Type

      • 10.1 Global Cancer Gene Therapy Revenue, Sales and Market Share by Type (2015-2020)
        • 10.1.1 Global Cancer Gene Therapy Sales and Market Share by Type (2015-2020)
        • 10.1.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2015-2020)
      • 10.2 Oncolytic Virotherapy Sales Growth Rate and Price
        • 10.2.1 Global Oncolytic Virotherapy Sales Growth Rate (2015-2020)
        • 10.2.2 Global Oncolytic Virotherapy Price
      • 10.3 Gene Transfer Sales Growth Rate and Price
        • 10.3.1 Global Gene Transfer Sales Growth Rate (2015-2020)
        • 10.3.2 Global Gene Transfer Price
      • 10.4 Gene-Induced Immunotherapy Sales Growth Rate and Price
        • 10.4.1 Global Gene-Induced Immunotherapy Sales Growth Rate (2015-2020)
        • 10.4.2 Global Gene-Induced Immunotherapy Price

      11 Global Cancer Gene Therapy Market Segment by Application

      • 11.1 Global Cancer Gene TherapySales Market Share by Application (2015-2020)
      • 11.2 Hospitals Sales Growth Rate (2015-2020)
      • 11.3 Diagnostics Centers Sales Growth Rate (2015-2020)
      • 11.4 Research Institutes Sales Growth Rate (2015-2020)

      12 Market Forecast for Cancer Gene Therapy

      • 12.1 Global Cancer Gene Therapy Revenue, Sales and Growth Rate (2020-2025)
      • 12.2 Cancer Gene Therapy Market Forecast by Regions (2020-2025)
        • 12.2.1 North America Cancer Gene Therapy Market Forecast (2020-2025)
        • 12.2.2 Europe Cancer Gene Therapy Market Forecast (2020-2025)
        • 12.2.3 Asia-Pacific Cancer Gene Therapy Market Forecast (2020-2025)
        • 12.2.4 South America Cancer Gene Therapy Market Forecast (2020-2025)
        • 12.2.5 Middle East & Africa Cancer Gene Therapy Market Forecast (2020-2025)
      • 12.3 Cancer Gene Therapy Market Forecast by Type (2020-2025)
        • 12.3.1 Global Cancer Gene Therapy Sales Forecast by Type (2020-2025)
        • 12.3.2 Global Cancer Gene Therapy Market Share Forecast by Type (2020-2025)
      • 12.4 Cancer Gene Therapy Market Forecast by Application (2020-2025)
        • 12.4.1 Global Cancer Gene Therapy Sales Forecast by Application (2020-2025)
        • 12.4.2 Global Cancer Gene Therapy Market Share Forecast by Application (2020-2025)

      13 Cancer Gene Therapy Related Market Analysis

      • 13.1 Upstream Analysis
        • 13.1.1 Macro Analysis of Upstream Markets
        • 13.1.2 Key Players in Upstream Markets
        • 13.1.3 Upstream Market Trend Analysis
        • 13.1.4 Manufacturing Cost Analysis
      • 13.2 Downstream Market Analysis
        • 13.2.1 Macro Analysis of Down Markets
        • 13.2.2 Key Players in Down Markets
        • 13.2.3 Downstream Market Trend Analysis
        • 13.2.4 Sales Channel, Distributors, Traders and Dealers

      14 Research Findings and Conclusion

        15 Appendix

        Summary:
        Get latest Market Research Reports on Cancer Gene Therapy. Industry analysis & Market Report on Cancer Gene Therapy is a syndicated market report, published as Global Cancer Gene Therapy Professional Survey Report 2020, Forecast to 2025. It is complete Research Study and Industry Analysis of Cancer Gene Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        		$3,280.00
        		$4,920.00
        		2,568.24
        		3,852.36
        		3,020.88
        		4,531.32
        		514,533.60
        		771,800.40
        		272,732.00
        		409,098.00
        Credit card Logo
        Sample Question Discount Download PDF

        Related Reports

        Reason to Buy

        • Trusted By Leaders

          Top executives from leading companies purchase research reports from us. 

        • Shop With Confidence

          We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

        • Customer Centric

          Need assistance related to your research requirements? We are just a phone call or an email away.

        • Personalized Solutions

          Our experienced research specialists are here to help you locate the right reports for your need.

        • Secure Checkout

          Shop without being worried about safety & security of your transactions.
          •

        Request for Sample of this report

        Reports and Markets

        mcafree

        Contact Us

        +1-352-353-0818 (US)

        info@reportsandmarkets.com

        Support

        EMAIL US

        Newsletter

        KEEP UP TO DATE ON ALL THE LATEST REPORTS


        maxmind_logo